Clinical Trial Update: Drug Drug Interactions of Aspirin and P2Y12-inhibitors [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating potential drug interactions between aspirin and P2Y12 inhibitors. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Aspirin (Aspirin)
• BRILINTA (ticagrelor)
• EFFIENT (prasugrel hydrochloride)
• Plavix (clopidogrel)

Snippet

Sponsor: Medical University of Vienna | Conditions: Drug Interaction Potentiation, Myocardial Infarction | Phase 4 | Status: COMPLETED